Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND
The blood coagulation cascade is an exquisite example of a responsive self-assembly process. When a wound if formed, a cascade of events is initiated. The net result of the cascade is an assembly of the globular protein fibrinogen, which is catalyzed by a second protein, thrombin, to
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND
The blood coagulation cascade is an exquisite example of a responsive self-assembly process. When a wound if formed, a cascade of events is initiated. The net result of the cascade is an assembly of the globular protein fibrinogen, which is catalyzed by a second protein, thrombin, to
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND
A wide variety of compositions and devices have been developed for use in controlling bleeding. However, available compositions and dressings typically have only a modest hemostatic effect, so that bleeding continues for several (e.g., 2-3 minutes or more) after application of composition
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND
A wide variety of compositions and devices have been developed for use in controlling bleeding. However, available compositions and dressings typically have only a modest hemostatic effect, so that bleeding continues for several (e.g., 2-3 minutes or more) after application of composition
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
This invention relates to mouthcare-products such as toothpastes, mouth rinsing liquids and medicinal mouthcare-compositions.
Well known toothpastes (as a paste, liquid form or as a powder form), mouth rinsing liquids (mouthwashes) and medicinal mouthcare preparations (e.g. preparations for
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD
This disclosure relates to methods and compositions to stop bleeding, and specifically to a composition comprising a hemostatic active ingredient and an astringent ingredient for clotting blood.
BACKGROUND
Approximately 90 million people in the United States have a nosebleed in their lifetime
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD
This disclosure relates to methods and compositions to stop bleeding, and specifically to a composition comprising a hemostatic active ingredient and an astringent ingredient for clotting blood.
BACKGROUND
Approximately 90 million people in the United States have a nosebleed in their lifetime
Baz done ki pi konplè remèd fèy medsin te apiye nan syans
Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive
Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont. * Tout enfòmasyon baze sou rechèch syantifik pibliye